Oak Grove Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Oak Grove Capital's ABBV Position: Q3 2026 in Review
Oak Grove Capital increased its AbbVie (ABBV) stake by 38% in Q3 2026, buying an estimated $4.36M and bringing the position to 61,750 shares worth $16.2M. The position accounts for 0.73% of the portfolio, ranked #31.
Oak Grove Capital first reported a position in ABBV in Q1 2018 and has held it in 20 quarters since. The position peaked at $23.2M in Q1 2022. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Oak Grove Capital held 61,750 shares of AbbVie worth $16.2M as of Q3 2026.
- Oak Grove Capital bought 17,000 AbbVie shares in Q3 2026, an estimated $4.36M.
- AbbVie made up 0.73% of Oak Grove Capital's portfolio in Q3 2026, its #31 holding.
- Oak Grove Capital first reported a position in AbbVie in Q1 2018 and has held it in 20 quarters since.
- Oak Grove Capital's AbbVie position peaked at $23.2M in Q1 2022.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Oak Grove Capital's 13F filing for Q3 2026, filed 9 Oct 2026.